Fate Therapeutics
FATE
#8864
Rank
โ‚ฌ0.10 B
Marketcap
0,94ย โ‚ฌ
Share price
-2.88%
Change (1 day)
-87.72%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of March 2025 (TTM): 8.61

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.3194. At the end of 2024 the company had a P/S ratio of 30.2.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202430.2420.86%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.18-28.22%๐Ÿ‡บ๐Ÿ‡ธ USA
3.20-62.85%๐Ÿ‡บ๐Ÿ‡ธ USA
4.62-46.27%๐Ÿ‡บ๐Ÿ‡ธ USA
360 4,086.96%๐Ÿ‡บ๐Ÿ‡ธ USA
4.81-44.08%๐Ÿ‡บ๐Ÿ‡ธ USA